Device Accessories - Understanding and Implementing the Final Guidance Document

Duration: 90 Minutes
The classification of device accessories has a high visibility. For example, the 21st Century Cures Act, signed into law in December 2016, amends the FD&CA to include accessory classification. It is very important, as a result, to apply the guidance document to your firm's products to determine if any of them are an accessory and as a result, ensure they meet the device regulations.
Accessories Guidance
Instructor: Daniel O'Leary
Product ID: 505201
Objectives of the Presentation
The presentation explains the final guidance document and provides an implementation approach
  • Learn the definition of an accessory and parent device from the guidance document - they are not in any regulations
  • Understand how the definition applies to "software as a medical device" SaMD
  • Understand the three prong approach to application of the accessory definition
  • Learn how to determine the classification status of an accessory
  • Understand the two methods of change applicable to a classified accessory
  • Understand the use of the de novo process for an unclassified accessory
Why Should you Attend
On December 30, 2016, FDA-CDRH+CBER issued the final guidance document to describe accessories and, in certain cases, provide a classification pathway. This is an important guidance document because it helps resolve an area of controversy and confusion. Under the Food, Drug, and Cosmetics Act (FD&CA) an accessory to a device is itself a device. The Unique Device Identification (UDI) rule, illustrates the confusion. The preamble includes a response to a request to define a device accessory. The response was, "No other medical device regulation has defined 'accessory' and the final rule does not include any requirement that specifically applies only to an accessory to a device and does not distinguish between accessories and other devices in any way". This left many device manufacturers unclear about which products require a UDI and how to complete the GUDID entries.

The final guidance document offers three major points for the discussion. First, it describes what FDA considers as an accessory, including a definition. The guidance document couples the definition of an accessory with a three-prong performance determination: support, supplement, or augment a parent device. This determination includes examples to help guide the determination as well as examples of products FDA does not consider as an accessory.

Second, it explains how to apply the device risk class system to accessories. Third, it covers issues of classification and reclassification with particular emphasis on using the de novo process for accessories not already classified.

The presentation explains the approach in the guidance document and gives you the tools needed to determine and document whether any of your products are an accessory.

Who will Benefit
Determining whether a product is an accessory requires a team to cover the various aspects in making the determination. Team members include:
  • Product Marketing Specialists
  • Regulatory Affairs Specialists
  • Device Quality Specialists
  • Design Engineering Managers
  • Production Managers
  • Product Documentation Specialists
  • Risk Management Specialists
Bonus Material
Participants receive a worksheet to help apply the definitions and determine if the accessory is classified. Participants also receive a copy of the guidance document.
$375
Recorded Session for one participant
Get life time access with download option!
Book this course
Pay Now
  $500.00 Training CD
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
  $600.00 Training USB Flash Drive
Free shipment within 4 Working Days of placing the order. Get life time access for unlimited participants.
For multiple location please contact our customer care team +1-510-857-5896.
How it works
Live Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • The webinar joining link, username and password for joining the webinar will be updated on your OCP Account 24 hours prior to the webinar
  • Presentation handouts in Downloadable PDF format will be updated on your OCP Account 24 hours prior to the live session
  • Login to the audio conference on the scheduled date and time
  • Get answers to your queries through interactive Q&A sessions via chat at the end of the session
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account 24 hours after the completion of the session
  • Please let us know your thoughts and views at the end of the webinar, your valuable feedback will help us improve
Recorded Session - How it works
  • Login to onlinecompliancepanel with your registered username and password https://www.onlinecompliancepanel.com/login
  • Upon purchase of the recorded session a link will be updated on your OCP Account within 24 hours
  • Please click on the link to access the Recorded Session
  • Presentation handouts in downloadable PDF format will be updated on your OCP Account within 24 hours of the purchase of the product
  • Download the Certificate of Attendance and Purchase Invoice from your OCP Account after 48 hours of the product Purchase
  • Please share your valuable Feedback at the end of the session
Instructor Profile:
Dan is the President of Ombu Enterprises, LLC, a company offering training and execution in Operational Excellence, focused on analytic skills and a systems approach to operations management. Dan has more than 30 years experience in quality, operations, and program management in regulated industries including aviation, defense, medical devices, and clinical labs. He has a Masters Degree in Mathematics; is an ASQ certified Biomedical Auditor, Quality Auditor, Quality Engineer, Reliability Engineer, and Six Sigma Black Belt; and is certified by APICS in Resource Management.
View More